| scholarly article | Q13442814 |
| P50 | author | Yves Sabbagh | Q42769442 |
| P2093 | author name string | Susan C Schiavi | |
| Stephen P O'Brien | |||
| Wenping Song | |||
| Adam Stockmann | |||
| Cynthia Arbeeny | |||
| Joseph H Boulanger | |||
| P2860 | cites work | Cloning and functional characterization of a sodium-dependent phosphate transporter expressed in human lung and small intestine | Q22010034 |
| Regulation of intestinal NaPi-IIb cotransporter gene expression by estrogen | Q24313133 | ||
| Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis | Q24671728 | ||
| Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production | Q28213962 | ||
| Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine | Q28508468 | ||
| Regulation of intestinal Na+-dependent phosphate co-transporters by a low-phosphate diet and 1,25-dihydroxyvitamin D3 | Q28571270 | ||
| Luminal fructose inhibits rat intestinal sodium-phosphate cotransporter gene expression and phosphate uptake | Q28576695 | ||
| Type II Na+-Pi cotransporters in osteoblast mineral formation: regulation by inorganic phosphate | Q28580024 | ||
| Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities | Q28587985 | ||
| Targeted deletion of the tybe IIb Na(+)-dependent Pi-co-transporter, NaPi-IIb, results in early embryonic lethality | Q28589668 | ||
| Na+-dependent phosphate transporters in the murine osteoclast: cellular distribution and protein interactions | Q28590054 | ||
| Regulation of the human sodium-phosphate cotransporter NaP(i)-IIb gene promoter by epidermal growth factor | Q31919480 | ||
| Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men. | Q34571933 | ||
| Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis | Q34580650 | ||
| Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study | Q34663424 | ||
| Rapid generation of inducible mouse mutants | Q34771977 | ||
| Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption | Q35840203 | ||
| Active intestinal calcium transport in the absence of transient receptor potential vanilloid type 6 and calbindin-D9k | Q36692068 | ||
| Type IIc sodium-dependent phosphate transporter regulates calcium metabolism | Q37042195 | ||
| Claudin tight junction proteins: novel aspects in paracellular transport. | Q37316276 | ||
| Novel mechanisms in the regulation of phosphorus homeostasis | Q37386445 | ||
| Mechanism and regulation of intestinal phosphate absorption | Q38002860 | ||
| 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism. | Q40172351 | ||
| 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport | Q40397501 | ||
| Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? | Q43890118 | ||
| Intestinal Na-P(i) cotransporter adaptation to dietary P(i) content in vitamin D receptor null mice | Q44783862 | ||
| Intestinal and renal adaptation to a low-Pi diet of type II NaPi cotransporters in vitamin D receptor- and 1alphaOHase-deficient mice | Q45219056 | ||
| Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure | Q46471367 | ||
| Relation between serum phosphate level and cardiovascular event rate in people with coronary disease | Q46772376 | ||
| Nicotinamide inhibits sodium-dependent phosphate cotransport activity in rat small intestine | Q48917210 | ||
| Regulation of intestinal phosphate transport. I. Segmental expression and adaptation to low-P(i) diet of the type IIb Na(+)-P(i) cotransporter in mouse small intestine. | Q54681432 | ||
| Relations of Serum Phosphorus and Calcium Levels to the Incidence of Cardiovascular Disease in the Community | Q57308708 | ||
| Absorption of Inorganic Phosphate in the Human Small Intestine | Q66922763 | ||
| Unidirectional influx of phosphate across the mucosal membrane of rabbit small intestine | Q70650148 | ||
| Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis | Q73804043 | ||
| Progress and rate of absorption of radiophosphorus through the intestinal tract of rats | Q78829089 | ||
| Intestinal phosphate absorption and the effect of vitamin D: a comparison of rats with mice | Q82348292 | ||
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 11 | |
| P304 | page(s) | 2348-2358 | |
| P577 | publication date | 2009-09-03 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | Intestinal npt2b plays a major role in phosphate absorption and homeostasis | |
| P478 | volume | 20 |
| Q49456531 | A Patient With CKD Develops Cholestatic Liver Injury During a Clinical Trial |
| Q33894092 | A physiologic-based approach to the evaluation of a patient with hyperphosphatemia |
| Q39354503 | Additive effects of fibroblast growth factor 23 neutralization and dietary phytase on chick calcium and phosphorus metabolism |
| Q34597741 | Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases |
| Q89521927 | All-trans retinoic acid reduces the transcriptional regulation of intestinal sodium-dependent phosphate co-transporter gene (Npt2b) |
| Q45720161 | An investigation of the effect of gastrointestinal microbial activity on oral arsenic bioavailability |
| Q51709073 | Antibody to fibroblast growth factor 23-peptide reduces excreta phosphorus of laying hens. |
| Q54863191 | Applied Pathology for Interventions of Coronary Chronic Total Occlusion. |
| Q92561776 | Approach to patients with hypophosphataemia |
| Q37244863 | Can features of phosphate toxicity appear in normophosphatemia? |
| Q90655716 | Clinical Potential of Targeting Fibroblast Growth Factor-23 and αKlotho in the Treatment of Uremic Cardiomyopathy |
| Q90443946 | Clinical aspects of the phosphate transporters NaPi-IIa and NaPi-IIb: mutations and disease associations |
| Q36535860 | Current concepts in perinatal mineral metabolism |
| Q35841012 | Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure |
| Q49476554 | Development and Characterization of a Human and Mouse Intestinal Epithelial Cell Monolayer Platform |
| Q38725971 | Dietary Phosphorus Intake and the Kidney. |
| Q41685533 | Dietary phosphate exacerbates intestinal inflammation in experimental colitis |
| Q88797838 | Discovery of Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Cotransporter NaPi2a (SLC34A1) |
| Q35995970 | Effect of Dietary Nutrient Density on Small Intestinal Phosphate Transport and Bone Mineralization of Broilers during the Growing Period |
| Q47412621 | Effect of Npt2b deletion on intestinal and renal inorganic phosphate (Pi) handling |
| Q59796459 | Effect of dietary phosphorus intake and age on intestinal phosphorus absorption efficiency and phosphorus balance in male rats |
| Q41351362 | Effects of 25-(OH)D3 on fecal Ca and P excretion, bone mineralization, Ca and P transporter mRNA expression and performance in growing female pigs |
| Q55253437 | Effects of Dietary Phosphorus Level on the Expression of Calcium and Phosphorus Transporters in Laying Hens. |
| Q36109201 | Effects of phosphate binders in moderate CKD |
| Q46799066 | Efficacy and safety of nicotinamide in the management of hyperphosphatemia in pediatric patients on regular hemodialysis |
| Q38821367 | Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling |
| Q35196150 | Evaluation of intestinal phosphate binding to improve the safety profile of oral sodium phosphate bowel cleansing |
| Q36923686 | Excessive fructose intake causes 1,25-(OH)(2)D(3)-dependent inhibition of intestinal and renal calcium transport in growing rats |
| Q39320633 | Experimental and regional variations in Na+-dependent and Na+-independent phosphate transport along the rat small intestine and colon |
| Q90236043 | Expression and function of Slc34 sodium-phosphate co-transporters in skeleton and teeth |
| Q90702820 | Expression of NaPi-IIb in rodent and human kidney and upregulation in a model of chronic kidney disease |
| Q42469601 | Expression of renal and intestinal Na/Pi cotransporters in the absence of GABARAP. |
| Q28075648 | Fibroblast Growth Factor-23-A Potential Uremic Toxin |
| Q37188744 | Gastrointestinal phosphate handling in CKD and its association with cardiovascular disease |
| Q46088111 | Genetic Knockout and Rescue Studies in Mice Unravel Abnormal Phosphorus Threshold in Hypophosphatemic Rickets |
| Q31044672 | High phosphorus diet-induced changes in NaPi-IIb phosphate transporter expression in the rat kidney: DNA microarray analysis |
| Q51896177 | Hypophosphatemia in vitamin D receptor null mice: effect of rescue diet on the developmental changes in renal Na+ -dependent phosphate cotransporters. |
| Q33770086 | Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial |
| Q38332329 | Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis |
| Q54355659 | Inorganic phosphate homeostasis in sodium-dependent phosphate cotransporter Npt2b⁺/⁻ mice. |
| Q36911899 | Insights from genetic disorders of phosphate homeostasis |
| Q53562681 | Intestinal Depletion of NaPi-IIb/Slc34a2 in Mice: Renal and Hormonal Adaptation. |
| Q58701703 | Intestinal Phosphorus Absorption in Chronic Kidney Disease |
| Q42506115 | Intestinal phosphate absorption is mediated by multiple transport systems in rats |
| Q91588283 | Intestinal phosphate absorption: The paracellular pathway predominates? |
| Q34768129 | Intestinal phosphate transport. |
| Q38185277 | Intestinal phosphate transport: a therapeutic target in chronic kidney disease and beyond? |
| Q37858474 | Klotho: a novel regulator of calcium and phosphorus homeostasis |
| Q36191156 | Liver X receptor-activating ligands modulate renal and intestinal sodium-phosphate transporters |
| Q89442831 | Mechanisms and Regulation of Intestinal Phosphate Absorption |
| Q92548203 | Mechanisms of phosphate transport |
| Q37627805 | Mice lacking the sodium-dependent phosphate import protein, PiT1 (SLC20A1), have a severe defect in terminal erythroid differentiation and early B cell development |
| Q34778791 | Mice with hypomorphic expression of the sodium-phosphate cotransporter PiT1/Slc20a1 have an unexpected normal bone mineralization. |
| Q34501455 | Modeling pulmonary alveolar microlithiasis by epithelial deletion of the Npt2b sodium phosphate cotransporter reveals putative biomarkers and strategies for treatment |
| Q34445193 | Molecular cloning and functional characterization of swine sodium dependent phosphate cotransporter type II b (NaPi-IIb) gene |
| Q85225964 | Mutation analysis and serum FGF23 level in a patient with pulmonary alveolar microlithiasis |
| Q28566881 | NHE3 regulatory factor 1 (NHERF1) modulates intestinal sodium-dependent phosphate transporter (NaPi-2b) expression in apical microvilli |
| Q49695446 | NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in CKD. |
| Q37148778 | Na+-independent phosphate transport in Caco2BBE cells. |
| Q84602487 | NaPi-IIa interacting proteins and regulation of renal reabsorption of phosphate |
| Q42396950 | Niacin for phosphate control: A case of David versus Goliath |
| Q38842982 | Nicotinamide and phosphate homeostasis in chronic kidney disease |
| Q26863371 | Non-systemic drugs: a critical review |
| Q38979089 | Novel developments in differentiating the role of renal and intestinal sodium hydrogen exchanger 3. |
| Q36280326 | Npt2b deletion attenuates hyperphosphatemia associated with CKD. |
| Q38892733 | Oral peptide specific egg antibody to intestinal sodium-dependent phosphate co-transporter-2b is effective at altering phosphate transport in vitro and in vivo |
| Q87936221 | Osmolality of Orally Administered Solutions Influences Luminal Water Volume and Drug Absorption in Intestine |
| Q35059741 | Osteo-renal regulation of systemic phosphate metabolism |
| Q38572880 | Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease. |
| Q34213752 | Pharmacology, efficacy and safety of oral phosphate binders |
| Q36965142 | Phosphate Toxicity in CKD: The Killer among Us |
| Q26853372 | Phosphate control in end-stage renal disease: barriers and opportunities |
| Q37763810 | Phosphate homeostasis and the renal-gastrointestinal axis |
| Q35059905 | Phosphate toxicity: new insights into an old problem |
| Q89964416 | Phosphorus Restriction Changes the Expression of Fibroblast Growth Factor 23 and Its Receptors in Laying Hens |
| Q48301736 | Postprandial adjustments in renal phosphate excretion do not involve a gut-derived phosphaturic factor |
| Q37034750 | Preclinical studies of VS-505: a non-absorbable highly effective phosphate binder |
| Q89357542 | Prenatal hyperechogenic kidneys in three cases of infantile hypercalcemia associated with SLC34A1 mutations |
| Q50913574 | Pulmonary Alveolar Microlithiasis. |
| Q37981914 | Pulmonary alveolar microlithiasis: a case report and review of the literature |
| Q36104887 | Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD. |
| Q34631794 | Recent advances in renal phosphate handling |
| Q38571301 | Regulation of renal phosphate handling: inter-organ communication in health and disease. |
| Q28568412 | Regulation of renal sodium-dependent phosphate co-transporter genes (Npt2a and Npt2c) by all-trans-retinoic acid and its receptors |
| Q38203228 | Renal handling of phosphate and sulfate |
| Q48351063 | Renal phosphate handling and inherited disorders of phosphate reabsorption: an update |
| Q34568797 | Renal phosphate wasting in the absence of adenylyl cyclase 6 |
| Q42683071 | Report on 2012 ISN Nexus symposium: 'Bone and the kidney'. |
| Q89703178 | Rickets |
| Q91458078 | Role of phosphate sensing in bone and mineral metabolism |
| Q90102237 | Role of αKlotho and FGF23 in regulation of type II Na-dependent phosphate co-transporters |
| Q54581678 | SGK3: a novel regulator of renal phosphate transport? |
| Q48232383 | SLC34A2 regulates miR-25-Gsk3β signaling pathway to affect tumor progression in gastric cancer stem cell-like cells |
| Q38028340 | Severe hyperphosphatemia after administration of sodium-phosphate containing laxatives in children: case series and systematic review of literature |
| Q38152465 | Significance of the anti-aging protein Klotho |
| Q92439873 | Skeletal mineralization: mechanisms and diseases |
| Q42656868 | Targeted Pth4-expressing cell ablation impairs skeletal mineralization in zebrafish |
| Q90324505 | Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease |
| Q60949633 | The Interplay of SIRT1 and Wnt Signaling in Vascular Calcification |
| Q38172416 | The SLC34 family of sodium-dependent phosphate transporters. |
| Q64269854 | The SLC34A2-ROS-HIF-1-induced up-regulation of EZH2 expression promotes proliferation and chemo-resistance to apoptosis in colorectal cancer |
| Q38708772 | The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147+ breast cancer stem cells |
| Q53184243 | The effects and mechanisms of SLC34A2 on tumorigenicity in human non-small cell lung cancer stem cells. |
| Q37789651 | The emergence of phosphate as a specific signaling molecule in bone and other cell types in mammals. |
| Q41477711 | The intestinal phosphate transporter NaPi-IIb (Slc34a2) is required to protect bone during dietary phosphate restriction |
| Q37771349 | The phosphate regulating hormone fibroblast growth factor-23. |
| Q57808852 | The role of SLC34A2 in intestinal phosphate absorption and phosphate homeostasis |
| Q34337575 | The role of the gastrointestinal tract in phosphate homeostasis in health and chronic kidney disease |
| Q36466010 | Treatment of phosphate retention: The earlier the better? |
| Q39432298 | Tumour-induced osteomalacia. |
| Q37199788 | Use of nicotinamide to treat hyperphosphatemia in dialysis patients |
| Q37620411 | Vitamin D endocrine system and the intestine |
Search more.